In This Article:
Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the appointment of Mr. Liang Lin as the new Chief Executive Officer of NuGen.
Liang is the founder and CEO of Sol-Millennium Medical Group ("SolM"), an organization committed to transforming the medical device sector through innovative approaches and a strong focus on patient safety. He initiated the SolM project in Shanghai, motivated by a vision to enhance health outcomes for patients globally. His unwavering commitment to innovation has led to the development of advanced medical devices that not only meet but exceed industry standards. Under Liang's dynamic leadership, SolM has made significant strides in expanding its international footprint. The organization has successfully penetrated the North American and Brazilian markets through strategic acquisitions, including Inviro Medical Inc. and Medica Brazil. Additionally, SolM has established offices across Europe and the Middle East, allowing the company to address a diverse range of healthcare needs and adapt to the unique challenges of various healthcare systems. To support its ambitious growth objectives, SolM has invested heavily in research and development, creating state-of-the-art facilities in both Asia and Europe. This commitment to R&D has enabled the company to build a robust pipeline of innovative products poised to make a significant impact on the medical device industry.
Liang will leverage his extensive knowledge and experience in the medical device field to drive innovation and growth at NuGen. His thorough understanding of industry trends, regulatory requirements, and technological advancements will enable the company to navigate the complexities of the market effectively. With his guidance, NuGen is expected to flourish, capitalizing on new opportunities and expanding its product offerings. Liang's strong leadership abilities position him to inspire and energize the team at NuGen, promoting a culture of collaboration and excellence.
Liang joined the Company's board of directors in September 2024 concurrently with the closing of Sol-M's strategic investment in NuGen.
"As NuGen's Chairman, over the past 4 months, I have been actively working with management to further understand InsuJet'sTM production capabilities in order to meet anticipated global demand in 2025. With this challenge, along with the Company being properly capitalized, I am honoured to assume the role of CEO. My goal is to leverage my experience and grow sales worldwide. I am confident that my expertise in the medical device industry will serve us very well and my object will be met," commented Liang Lin, Chairman and CEO of NuGen.